WEBSITECHANGES

Website Changes

---

10/01/2015

Multicenter study shows Monteris’ NeuroBlate System improves outcome in brain tumor patients

---

09/30/2015

IBTA Newsletter

---

09/28/2015

International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme.

---

09/28/2015

5th Annual Chili Cook Off October 3, 2015 Saturday 11 am – 5 pm NJ

---

09/20/2015

EnGeneIC Ltd. to Initiate U.S. Phase 1 Clinical Study Using Targeted EDV™ Nanocells to Treat Advanced Glioma Patients

---

09/20/2015

Brain cancer drug approved for NZ

---

09/20/2015

Caffeine inhibits the growth of glioblastomas through activating the caspase-3 signaling pathway in vitro.

---

09/12/2015

Novocure to Present the Latest Data from the EF-14 Clinical Trial in Newly Diagnosed GBM at the 15th Interim Meeting of the World Federation of Neurosurgical Societies

---

09/12/2015

Life After Brain Cancer Diagnosis: Max`s Story

---

09/08/2015

Novocure Announces Optune® Now Available at more than 200 Leading Cancer Centers across the United States

---

09/04/2015

Voices Against Brain Cancer is now accepting Brain Tumor Research Grant Requests

---

09/01/2015

UCLA Researchers Develop a Likely New Combo Treatment for the Deadliest Form of Brain Cancer

---

09/01/2015

Oncoceutics Awarded Grant for Phase II Brain Cancer Trial

---

08/31/2015

IBTA Newsletter

---

08/29/2015

Computed modeling of alternating electric fields therapy for recurrent glioblastoma.

---

08/26/2015

WEBINAR ALERT: Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Clinical Trials

---

08/26/2015

Enrollment Begins In Expansion Phase of ONC201 Clinical Trial

---

08/26/2015

Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study.

---

08/25/2015

FDA Grants Orphan Drug Designation for Tocagen`s Toca 511 & Toca FC, an Investigational Immuno-Oncology Treatment for Glioblastoma

---

08/24/2015

?Celldex and the limits of ‘overall survival benefit’ in cancer trials

---

08/24/2015

Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps Due to Failure to Meet Child-Resistant Closure Requirement

---

08/24/2015

NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing Patients In Trial Continuing To Be Treated Per Protocol, Including In Germany

---

08/24/2015

Update posted for Ben Williams` "Treatment Options for Glioblastoma and other Gliomas"

---

08/17/2015

San Diego couple trying to stop time with Novocure

---

08/17/2015

Added survivor story Debbie - 10 year GBM survivor!

---